טוען...
A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5)
Human respiratory syncytial virus (RSV) is a leading cause of severe respiratory disease and hospitalizations in infants and young children. It also causes significant morbidity and mortality in elderly and immune compromised individuals. No licensed vaccine currently exists. Parainfluenza virus 5 (...
שמור ב:
| Main Authors: | , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4039636/ https://ncbi.nlm.nih.gov/pubmed/24717150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.03.049 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|